FOSTER CITY, Calif.--(BUSINESS WIRE)-- Mirum Pharmaceuticals, Inc. (MIRM), a leading rare disease company, today announced completion of enrollment in the Phase 3 AZURE-1 study and completion of ...
Version 4.1 of the Network File System protocol is now supported on Azure Files. It will be provided to customers in the form of a fully managed NFS file system as a service, in preview for now. With ...
- AZURE-1 and AZURE-4 to form the basis of Mirum’s U.S. BLA Submission Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced completion of enrollment in the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results